Incremental costs per 10 000 population and quality adjusted life years (QALYs) gained per 100 000 population, comparing vaccinations strategies for elderly people and high transmitters (vaccine available early in pandemic, no immunity present) for the Netherlands and Germany (direct healthcare costs (€), discounted (Germany 5%, Netherlands 1.5%) and without discounting, price level 2008)